Paul A. Johnston

6.9k total citations
148 papers, 5.4k citations indexed

About

Paul A. Johnston is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul A. Johnston has authored 148 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 34 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul A. Johnston's work include Receptor Mechanisms and Signaling (12 papers), Cell Image Analysis Techniques (10 papers) and Cancer Cells and Metastasis (9 papers). Paul A. Johnston is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Cell Image Analysis Techniques (10 papers) and Cancer Cells and Metastasis (9 papers). Paul A. Johnston collaborates with scholars based in United States, United Kingdom and Australia. Paul A. Johnston's co-authors include Thomas C. Südhof, Jennifer R. Grandis, Shilpa Sant, Reinhard Jahn, John S. Lazo, Tong Ying Shun, Patricia A. Johnston, David A. Close, Peter Wipf and Helen L. Yin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul A. Johnston

141 papers receiving 5.3k citations

Peers

Paul A. Johnston
Weiming Xu China
Christine Le Roy France
Yosuke Hashimoto Japan
Edward H. Cho United States
Marc Ferrer United States
Bernd Wollscheid Switzerland
Christian Schnell Switzerland
Jeffrey Field United States
Xiaobo Wang China
Weiming Xu China
Paul A. Johnston
Citations per year, relative to Paul A. Johnston Paul A. Johnston (= 1×) peers Weiming Xu

Countries citing papers authored by Paul A. Johnston

Since Specialization
Citations

This map shows the geographic impact of Paul A. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Johnston more than expected).

Fields of papers citing papers by Paul A. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Johnston. The network helps show where Paul A. Johnston may publish in the future.

Co-authorship network of co-authors of Paul A. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Johnston. A scholar is included among the top collaborators of Paul A. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Johnston. Paul A. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Close, David A., et al.. (2024). Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051. Bioorganic & Medicinal Chemistry Letters. 108. 129810–129810. 1 indexed citations
2.
Przepiorski, Aneta, Veronika Sander, David A. Close, et al.. (2022). Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury. ACS Pharmacology & Translational Science. 5(4). 207–215. 11 indexed citations
3.
4.
5.
Shan, Feng, David A. Close, Daniel P. Camarco, & Paul A. Johnston. (2017). High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer. Assay and Drug Development Technologies. 16(1). 27–50. 28 indexed citations
6.
Hua, Yun, et al.. (2016). Reconfiguring the AR-TIF2 Protein–Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen. Assay and Drug Development Technologies. 14(8). 453–477. 10 indexed citations
7.
Johnston, Paul A., Minh M. Nguyen, Javid A. Dar, et al.. (2016). Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells. Assay and Drug Development Technologies. 14(4). 226–239. 24 indexed citations
8.
Feng, Zhiwei, David A. Close, Lirong Wang, et al.. (2015). Design and activity of AP endonuclease-1 inhibitors. PubMed. 8(3). 79–93. 29 indexed citations
9.
Johnston, Paul A., Malabika Sen, Yun Hua, et al.. (2013). High-Content pSTAT3/1 Imaging Assays to Screen for Selective Inhibitors of STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. Assay and Drug Development Technologies. 12(1). 55–79. 28 indexed citations
10.
McInnes, Campbell, Zhengguan Yang, Paul A. Johnston, et al.. (2012). Targeting Subcellular Localization through the Polo-Box Domain: Non-ATP Competitive Inhibitors Recapitulate a PLK1 Phenotype. Molecular Cancer Therapeutics. 11(8). 1683–1692. 18 indexed citations
11.
Johnston, Paul A., Sunita N. Shinde, Yun Hua, et al.. (2012). Development and Validation of a High-Content Screening Assay to Identify Inhibitors of Cytoplasmic Dynein-Mediated Transport of Glucocorticoid Receptor to the Nucleus. Assay and Drug Development Technologies. 10(5). 432–456. 21 indexed citations
12.
Daghestani, Hikmat N., Guangyu Zhu, Paul A. Johnston, et al.. (2011). Characterization of Inhibitors of Glucocorticoid Receptor Nuclear Translocation: A Model of Cytoplasmic Dynein-Mediated Cargo Transport. Assay and Drug Development Technologies. 10(1). 46–60. 13 indexed citations
13.
Blackmon, Nicole L., Tong Ying Shun, Sunita N. Shinde, et al.. (2010). Profiling the NIH Small Molecule Repository for Compounds That Generate H 2 O 2 by Redox Cycling in Reducing Environments. Assay and Drug Development Technologies. 8(2). 152–174. 91 indexed citations
14.
Johnston, Paul A., Sunita N. Shinde, Caleb Foster, et al.. (2008). Development of a 384-Well Colorimetric Assay to Quantify Hydrogen Peroxide Generated by the Redox Cycling of Compounds in the Presence of Reducing Agents. Assay and Drug Development Technologies. 6(4). 505–518. 96 indexed citations
15.
Johnston, Paul A., Caleb Foster, Tong Ying Shun, et al.. (2007). Development and Implementation of a 384-Well Homogeneous Fluorescence Intensity High-Throughput Screening Assay to Identify Mitogen-Activated Protein Kinase Phosphatase-1 Dual-Specificity Protein Phosphatase Inhibitors. Assay and Drug Development Technologies. 5(3). 319–332. 33 indexed citations
16.
Johnston, Paul A., Jennifer Phillips, Tong Ying Shun, et al.. (2007). HTS Identifies Novel and Specific Uncompetitive Inhibitors of the Two-Component NS2B-NS3 Proteinase of West Nile Virus. Assay and Drug Development Technologies. 5(6). 737–750. 85 indexed citations
17.
Pratt, Susan E., Robert L. Shepard, Ramani A. Kandasamy, et al.. (2005). The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Molecular Cancer Therapeutics. 4(5). 855–863. 186 indexed citations
18.
Johnston, Paul A.. (1998). On the trail of Leonardo.. PubMed. 158(6). 777–9. 2 indexed citations
19.
Wright, C., Kilian Mellon, Paul A. Johnston, et al.. (1991). Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. British Journal of Cancer. 63(6). 967–970. 153 indexed citations
20.
Wright, C, et al.. (1990). Expression of c-erbB-2 protein product in bladder cancer. British Journal of Cancer. 62(5). 764–765. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiming Xu Breakdown of academic impact, for papers by Christine Le Roy Breakdown of academic impact, for papers by Yosuke Hashimoto Breakdown of academic impact, for papers by Edward H. Cho Breakdown of academic impact, for papers by Marc Ferrer Breakdown of academic impact, for papers by Bernd Wollscheid Breakdown of academic impact, for papers by Christian Schnell Breakdown of academic impact, for papers by Jeffrey Field Breakdown of academic impact, for papers by Xiaobo Wang
Rankless by CCL
2026